Fig. 3From: Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trialChange in serum uric acid from baseline to week 12. (A) Serum uric acid level among all participants. (B) Serum uric acid level among participants with gout. (C) Change in serum uric acid level among all participants. (D) Change in serum uric acid level among participants with goutBack to article page